NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...
Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
For clinicians, bladder stones (vesical calculi) are less a disease and more a symptom of a deeper problem, usually stasis or obstruction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback